Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04186546 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Zephyr Valve Registry (ZEVR)

Study acronym: ZEVR
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: details revised at 4 of 12 entries
    • Publications: details revised at 11 of 11 entries
    • Eligibility criteria expanded, about 2 words
  2. Primary completion date: Dec 31, 2024 to Dec 31, 2026v15
  3. Study sites: 9 to 11v14
  4. Primary completion date: Dec 31, 2023 to Dec 31, 2024
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 10 to 9
    • Study completion date: Mar 31, 2027 to Dec 31, 2026
    v13
  5. Study completion date: Dec 31, 2025 to Mar 31, 2027v12
Show 10 earlier versionsHide 10 earlier versions
  1. Primary completion date: Dec 31, 2022 to Dec 31, 2023
    • Study sites: 9 to 10
    • Study completion date: Dec 31, 2024 to Dec 31, 2025
    v11
  2. Primary completion date: Dec 31, 2021 to Dec 31, 2022
    • Site details revised at 2 of 9 sites
    v10
  3. Site contacts updated at 3 of 9 sitesv9
  4. Site details revised at 1 of 9 sitesv8
  5. Site details revised at 2 of 9 sitesv7
  6. Trial status: Enrolling by Invitation to Recruiting
    • Site details revised at 9 of 9 sites
    v6
  7. Study sites: 3 to 9v5
  8. Study sites: 2 to 3v4
  9. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Study sites: 0 to 2
    • Start date changed from estimate of Nov 30, 2019 to Nov 25, 2019
    v3
  10. Secondary endpoints: details revised at 1 of 12 entriesv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Pulmonx Corporation
4 trials monitored
See all monitored trials
COPD
1,119 trials monitored
See 34 trials at risk
The purpose of this Post-Approval Registry is to gather ongoing safety and effectiveness assessment of the Zephyr Valve treatment in a real-world setting.
Trial Details
NCT Number NCT04186546
Lead Sponsor Pulmonx Corporation
Conditions
(from sponsor)		 Emphysema
Related terms Emphysema
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov